OncoZenge AB (publ) (STO:ONCOZ)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.86
-0.29 (-4.06%)
Jul 24, 2026, 4:53 PM CET

OncoZenge AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.122.78000-
Revenue Growth
-95.58%278300.00%-66.67%---
Gross Profit
0.122.78000-
Operating Income
-32.38-15.79-8.69-15.9-43.57-4.89
Net Income
-23.12-15.94-8.69-15.9-46.65-3.89
Earnings Per Share
-1.82-1.31-0.74-1.36-3.98-0.33
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.943.713.8612.6329.1451.22
Total Debt
7.57.50000
Net Cash (Debt)
-6.57-3.793.8612.6329.1451.22
Net Cash Growth
---69.41%-56.67%-43.11%412.23%
Net Cash Per Share
-0.52-0.310.331.082.494.37

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-21.98-13.06-8.76-17.08-22.08-4.77
Free Cash Flow
-21.98-13.06-8.76-17.08-22.08-4.77
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-26985.00%-567.06%-868500.00%-530067.00%--
Pretax Margin
-19263.33%-572.56%-868800.00%-530066.67%--
Profit Margin
-19263.30%-572.56%-868800.00%-530067.00%--
FCF Margin
-18313.30%-469.00%-876400.00%-569433.00%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1414.7030.7143924.7012064.60--